Thomas Mueller | Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology"
Federal Ministry of Health Germany

Thomas Mueller, Head Of Directorate General 1

Thomas Müller is Medical Doctor and Pharmacist. He completed his studies in Berlin and London, and then worked in the Dermatology Department of the University Hospital Charité Berlin. He completed postgraduate studies in business administration. Subsequently, he worked for several years in the Hospital Pharmacy Departments of the University Hospitals of Erlangen and Rostock. He became director of the hospital pharmacy and the medical purchasing of the University Hospital of Rostock.

Since 2007, Thomas Müller is head of the Pharmaceuticals Department of the Federal Joint Committee (G-BA) in Berlin. He is assistant professor at the University of Bonn (Regulatory Drug Affairs) and Paris-Sorbonne (International Market Access).

As part of his work at the G-BA, Thomas Müller has played a key role in successfully designing, planning, and implementing the early benefit assessment (AMNOG) in Germany.


Conference Day 1: Thursday 16th May 2019 @ 17:25

Panel discussion: Finding the right framework for reimbursement and market access for cell and gene therapies

· Structured reimbursement system for hospital-based treatments in Europe· What is possible for statutory health insurance framework in the EU?· Contract possibilities with manufacturers, hospitals and insurance providers
last published: 21/Mar/19 09:25 GMT

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.


Erica Baeta 
+44 (0)207 092 1152


Jessica Robinson 
t/ +44 (0)207 092 1150


Issa Mauthoor 
+44 (0)207 092 1257